AlphaCore Capital »

Immunitybio shares owned by AlphaCore Capital

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by AlphaCore Capital from 13F filings

Historical chart of AlphaCore Capital investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by AlphaCore Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by AlphaCore Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.4M 3.0M 2.46
2025-06-30 $7.9M 3.0M 2.64

More positions owned by AlphaCore Capital

Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Meta Platforms Cl A (META)
Schwab Strategic Tr Fundamental Us L (FNDX)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
MPLX Com Unit Rep Ltd (MPLX)
Schwab Strategic Tr Fundamental Intl (FNDF)
Ishares Tr Core Msci Total (IXUS)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Etf Ser Solutions Distillate Us (DSTL)
Ishares Tr Russell 3000 Etf (IWV)
Apple (AAPL)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Invesco Exchange Traded Fd T Rafi Us 1000 Etf (PRF)
Microsoft Corporation (MSFT)
American Centy Etf Tr Us Sml Cp Valu (AVUV)

View all positions for AlphaCore Capital

Top funds holding Immunitybio

Vanguard Group
BlackRock
Jane Street
State Street Corporation
Geode Capital Management
Heights Capital Management
Woodline Partners
Susquehanna International
AlphaCore Capital
Morgan Stanley
Two Sigma Investments
Tang Capital Management
Charles Schwab Investment Management
Citadel Advisors
Northern Trust

View all funds holding Immunitybio